The Pharma Data

NOVEMBER 18, 2020

Department of Internal Medicine, Tri-Service General Hospital, Taipei, Taiwan. Title: OBI-833 was safe and immunogenic, without treatment-related SAEs, in a Phase 1 dose-escalation trial. Session Title: E-poster Display session – Thoracic tumours, metastatic. Session Date and Time: Friday, November 20, 2020.

Vaccine 52

Vaccine Small Molecule Immune Response Hospitals 52

The Pharma Data

DECEMBER 14, 2020

The global GBM treatment market is projected to reach $3.3 The ability of a drug candidate to cross the blood brain barrier is of critical importance in treatment outcomes for CNS and brain cancers. It is considered an orphan disease for which there is no cure. representing the largest market.

DNA 52

DNA Clinical Trials Drugs Therapies 52

Drug Discovery World

JUNE 6, 2023

This work has since been applied to the development of treatments for late-stage melanoma and leukaemia, and is in development for several other malignancies. He is also a professor of medicine and immunology at the University of Washington School of Medicine.

Small Molecule 130

Small Molecule DNA RNA Research 130

KIF1A

MAY 31, 2024

From hosting a conference to scientific projects and collaborations to the dedicated efforts of our team, this review encapsulates the relentless pursuit to accelerate treatments and a cure for all KAND warriors. The Chung Lab spearheads a robust KAND program to better understand the disorder and discover treatments.

Small Molecule 52

Small Molecule Treatment International Research 52

The Pharma Data

AUGUST 3, 2021

The FDA has broadened the Emergency Use Authorization (EUA) for baricitinib to allow for treatment with or without remdesivir. The European Commission granted marketing authorization for Jardiance ® as a treatment for adults with symptomatic chronic heart failure with reduced ejection fraction (systolic heart failure).

Production 52

Production Marketing Research Government 52

The Pharma Data

OCTOBER 26, 2020

V590 — a SARS-CoV-2 vaccine candidate in development in collaboration with the International AIDS Vaccine Initiative (IAVI) that uses a recombinant vesicular stomatitis virus (rVSV) platform, the same platform used for Merck’s approved Ebola Zaire virus vaccine, will enter Phase 1 development shortly.

Vaccine 40

Vaccine Trials Licensing Licensing 40

Drug Discovery World

JANUARY 12, 2023

The genome is the blueprint for life, consisting of genes made up of thousands of pairs of DNA bases. Small molecule drugs or biologics need to be delivered via blood vessels and penetrate tissue to get into cells. Organoids will also advance personalised medicine. About the author .

Drugs 246

Drugs Disease Drug Development Therapies 246

The Pharma Data

DECEMBER 21, 2020

21 December 2020 — AstraZeneca’s Tagrisso ( osimertinib ) has been approved in the US for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after tumour resection with curative intent. 0.23; p<0.0001).

Treatment 52

Treatment Trials Disease FDA 52

Vial

FEBRUARY 19, 2024

I always had the concept of morbidity of medicine and trying to find treatments for patients that are safe and effective and doesn’t have a lot of side effects. All in all, the idea is to prevent the morbidity of medicine and to give patients treatments that have a better safety and efficacy profile.

Small Molecule 52

Small Molecule Therapies Treatment Science 52

Codon

MAY 30, 2023

This week: A way to measure a transgene’s expression in the brain using ultrasound, a DNA sequencing method that uses 1000x less reagents, and base editors get even smaller. An engineered version of this protein can convert DNA bases with efficiencies up to 92%. so this Digest will be published more irregularly.

DNA 52

DNA RNA Engineering Vaccine 52

Codon

MAY 30, 2023

This week: A way to measure a transgene’s expression in the brain using ultrasound, a DNA sequencing method that uses 1000x less reagents, and base editors get even smaller. An engineered version of this protein can convert DNA bases with efficiencies up to 92%. so this Digest will be published more irregularly.

DNA 52

DNA RNA Engineering Vaccine 52

The Pharma Data

DECEMBER 27, 2020

Azura Ophthalmics announced topline data from its Phase III ECLIPTIC trial of AZR-MD-001 for treatment of contact lens discomfort. Transgene and BioInvent International received regulatory approval in Belgium for a Phase I/IIa trial of oncolytic Vaccinia virus BT-001. It reduced the risk of disease progression or death by 78%.

Clinical Trials 52

Clinical Trials Trials Therapies RNA 52

Agency IQ

APRIL 19, 2024

Treatment for MM may be lifelong, with patient and disease characteristics guiding the course of treatment. Patients frequently receive up to four therapies at once and go through multiple prolonged courses of treatment to keep recurrence and progression at bay.

FDA 40

FDA Disease Trials Clinical Trials 40

The Premier Consulting Blog

APRIL 25, 2023

In the US, new small molecule drugs are developed under the requirements of Sections 505(b)(1) and 505(b)(2) of the FFDCA. Synthroid® oral tablets) were marketed as unapproved drugs for the treatment of hypothyroidism in the US. This strategy can reduce the overall study requirements for approval. [1]

FDA 52

FDA Animal Testing Pharmacokinetics Small Molecule 52